Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation
- 19 February 2007
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 46 (10) , 1716-1718
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)Chemical Reviews, 2006
- Evaluation of Drug Penetration into the Brain: A Double Study by in Vivo Imaging with Positron Emission Tomography and Using an in Vitro Model of the Human Blood-Brain BarrierThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer DiseaseArchives of Neurology, 2003
- The metallobiology of Alzheimer's diseaseTrends in Neurosciences, 2003
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MiceNeuron, 2001
- New concepts of iron and aluminium chelation therapy with oral L1 (deferiprone) and other chelators. A reviewThe Analyst, 1995
- Copper Complexation by 3-Hydroxypyridin-4-one Iron Chelators: Structural and Iron Competition StudiesJournal of Medicinal Chemistry, 1994
- Mechanism of Agrobacterium .beta.-glucosidase: kinetic studiesBiochemistry, 1992
- Intramuscular desferrioxamine in patients with Alzheimer's diseaseThe Lancet, 1991
- Stability Constants of Some Metal Complexes Formed by Mimosine and Related CompoundsAustralian Journal of Chemistry, 1979